Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges

Journal of Antimicrobial Chemotherapy · Published 2026-07-21 · DOI 10.1093/jac/dkag266

Authors (55)

Alexandra Serris, François Danion, Joseph Benzakoun, Pierre Tattevin, Jean-Pierre Gangneux, Renaud Verdon, Julie Bonhomme, Lucie Lelièvre, Yacine Tandjaoui-Lambiotte, Thorsten Braun, Jean-Philippe Talarmin, Guillaume Desoubeaux, Claire Aguilar, Olivier Lortholary, David Ghez, Fanny Lanternier, CEREALS study group, Florence Ader, Samy Ammari, Charlotte Barbier, Philippe Blanche, Françoise Botterel, Pierre-Yves Brillet, Sophie Brun, Jean-Philippe Cottier, François Cotton, Eric Dannaoui, François Eugene, Loïc Favennec, Arnaud Fekkar, Sophie Gallas, Jean-Pierre Gangneux, Gaëlle Guillerm, Elie Haddad, Philippe Halimi, Lilia Hasseine, Guillaume Hekimian, Raoul Herbrecht, Stéphane Kremer, Marie-Pierre Ledoux, Valérie Letscher-Bru, Liem Binh Luong Nguyen, Aude Marie-Cardine, Armand Mekontso Dessap, André Paugam, Florence Persat, Raphaël Porcher, Valérie Pourcher, Nadya Pyatigorskaya, Marie-Pierre Revel, Christine Robin, Benjamin Terrier, Dominique Toubas, Renaud Vernon, Martine Wallon

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Serris, A., Danion, F., Benzakoun, J., et al. (2026). Cerebral aspergillosis under ibrutinib therapy: clinical features and management challenges. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag266

Related articles